Histiocytic Disorders clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
“Assessing new blood cells growth after transplant using cord blood units that do not meet FDA guidelines but meet NMDP guidelines”
open to all eligible people
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
at UCLA UCSD UCSF
Our lead scientists for Histiocytic Disorders research studies include Edward Ball, MD Gary Schiller, MD Thomas Martin, MD Sandhya Kharbanda, MD Mark Walters, MD.